142 related articles for article (PubMed ID: 7479461)
21. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
22. Carcinoma of the colon and rectum. A perspective for practicing physicians, with recommendations for screening.
Dean TM
West J Med; 1977 Jun; 126(6):431-40. PubMed ID: 878459
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity and specificity of the fecal occult blood test for colorectal neoplasia.
Winawer SJ; Fleisher M
Gastroenterology; 1982 May; 82(5 Pt 1):986-91. PubMed ID: 7060917
[No Abstract] [Full Text] [Related]
24. Continued assessment of flexible sigmoidoscopy in a family practice residency.
Johnson RA; Quan M; Rodney WM
J Fam Pract; 1984 May; 18(5):723-7. PubMed ID: 6716069
[TBL] [Abstract][Full Text] [Related]
25. [Individual screening for colorectal cancer: which strategy for which patient?].
Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
[TBL] [Abstract][Full Text] [Related]
26. Are there markers for the risk of colorectal cancer?
Sherlock P; Winawer SJ
N Engl J Med; 1984 Jul; 311(2):118-9. PubMed ID: 6738589
[No Abstract] [Full Text] [Related]
27. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
[TBL] [Abstract][Full Text] [Related]
28. Screening for colorectal cancer. Use of a new protocol may reduce death rates.
Lush DT
Postgrad Med; 1994 Jul; 96(1):99-106. PubMed ID: 8022720
[TBL] [Abstract][Full Text] [Related]
29. Screening for rectal cancer: will it improve cure rates?
Tweedle EM; Rooney PS; Watson AJ
Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):639-48. PubMed ID: 17764916
[TBL] [Abstract][Full Text] [Related]
30. Large bowel adenomas: markers of risk and endpoints.
Baron JA
J Cell Biochem Suppl; 1996; 25():142-8. PubMed ID: 9027611
[TBL] [Abstract][Full Text] [Related]
31. Screening for colorectal cancer.
Kartha CC
Natl Med J India; 1993; 6(3):134-5. PubMed ID: 8329993
[No Abstract] [Full Text] [Related]
32. Colorectal cancer screening: present strategies and future prospects.
Marshall JB
Postgrad Med; 1996 Mar; 99(3):253-64. PubMed ID: 8637834
[TBL] [Abstract][Full Text] [Related]
33. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
34. The potential role of fecal carbonic anhydrase II in screening for colorectal cancer.
Yokoyama S; Shatney CH; Mochizuki H; Hase K; Johnson DL; Cummings S; Trollope ML; Tamakuma S
Am Surg; 1997 Mar; 63(3):243-6; discussion 246-7. PubMed ID: 9036892
[TBL] [Abstract][Full Text] [Related]
35. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.
Weissfeld JL; Schoen RE; Pinsky PF; Bresalier RS; Church T; Yurgalevitch S; Austin JH; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Jul; 97(13):989-97. PubMed ID: 15998952
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
37. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
38. Colon cancer screening strategies.
Agrawal J; Syngal S
Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
[TBL] [Abstract][Full Text] [Related]
39. Retroflexion of the sigmoidoscope for the detection of rectal cancer.
Esber EJ; Yang P
Am Fam Physician; 1995 May; 51(7):1709-11. PubMed ID: 7754930
[TBL] [Abstract][Full Text] [Related]
40. Colorectal cancer screening: an overview of available methods and current recommendations.
Early DS
South Med J; 1999 Mar; 92(3):258-65. PubMed ID: 10094264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
